+Search query
-Structure paper
Title | RLY-4008, the First Highly Selective FGFR2 Inhibitor with Activity across FGFR2 Alterations and Resistance Mutations. |
---|---|
Journal, issue, pages | Cancer Discov, Vol. 13, Page 2012-2031, Year 2023 |
Publish date | May 10, 2023 (structure data deposition date) |
Authors | Subbiah, V. / Sahai, V. / Maglic, D. / Bruderek, K. / Toure, B.B. / Zhao, S. / Valverde, R. / O'Hearn, P.J. / Moustakas, D.T. / Schonherr, H. ...Subbiah, V. / Sahai, V. / Maglic, D. / Bruderek, K. / Toure, B.B. / Zhao, S. / Valverde, R. / O'Hearn, P.J. / Moustakas, D.T. / Schonherr, H. / Gerami-Moayed, N. / Taylor, A.M. / Hudson, B.M. / Houde, D.J. / Pal, D. / Foster, L. / Gunaydin, H. / Ayaz, P. / Sharon, D.A. / Goyal, L. / Schram, A.M. / Kamath, S. / Sherwin, C.A. / Schmidt-Kittler, O. / Jen, K.Y. / Ricard, F. / Wolf, B.B. / Shaw, D.E. / Bergstrom, D.A. / Watters, J. / Casaletto, J.B. |
External links | Cancer Discov / PubMed:37270847 |
Methods | X-ray diffraction |
Resolution | 3.79 Å |
Structure data | PDB-8stg: |
Chemicals | ChemComp-WCJ: |
Source |
|
Keywords | TRANSFERASE/INHIBITOR / Relay Inhibitor / CYTOSOLIC PROTEIN / TRANSFERASE-INHIBITOR complex |